US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Autonomix Medical Inc

1.11

-0.1500-11.90%

Post-market: 1.05-0.0600-5.41%19:48 EDT

Volume:868.18K

Turnover:998.93K

Market Cap:6.60M

PE:-0.09

High:1.22

Open:1.22

Low:1.08

Close:1.26

52wk High:21.49

52wk Low:0.9612

Shares:5.94M

Float Shares:5.57M

Volume Ratio:0.82

T/O Rate:15.60%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-12.8569

EPS(LYR):-21.0935

ROE:-195.57%

ROA:-95.20%

PB:0.94

PE(LYR):-0.05

Loading ...

Overview Company News Filings

Autonomix Medical, Inc. Exercise of Warrants for $2.5 Million Gross Proceeds

Autonomix Medical, Inc. Granted New U.S. Patent to Advance Minimally Invasive, Nerve-Focused Treatments Across High-Need Indications

Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment

BRIEF-Autonomix Medical Inc - Enrolls First Patient In Poc 2 Clinical Trial

BRIEF-Autonomix Medical Granted US Patent for Innovative Catheter-Based Platform Technology for Nerve Therapy

Autonomix Medical Approved to Begin Testing Treatment for Cancer-Related Pain in Uzbekistan

MT Newswires Live

Autonomix Medical Inc. Reports Uncertain Revenue Outlook Amid Ongoing R&D Expenses; Net Loss Widens as EPS Declines

BRIEF-Autonomix Medical Reports Positive Outcomes In Initial Phase Of First-In-Human Proof-Of-Concept Trial In Pancreatic Cancer Pain And Initiates Market Expansion Study For Visceral Cancer Pain

Autonomix Medical Initiated at Buy by Maxim Group

Maxim Group Initiates Coverage on Autonomix Medical With Buy Rating, $5 Price Target

MT Newswires Live

BRIEF-Autonomix Medical Granted New European Patent For Proprietary Catheter-Based Technology

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AMIX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AMIX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AMIX\",,,,,undefined,":{"symbol":"AMIX","market":"US","secType":"STK","nameCN":"Autonomix Medical Inc","latestPrice":1.11,"timestamp":1760126400000,"preClose":1.26,"halted":0,"volume":868175,"hourTrading":{"tag":"盘后","latestPrice":1.05,"preClose":1.11,"latestTime":"19:48 EDT","volume":32335,"amount":35213.2275,"timestamp":1760140089860},"delay":0,"floatShares":5565185,"shares":5941992,"eps":-12.856861,"marketStatus":"Market Closed","change":-0.15,"latestTime":"10-10 16:00:00 EDT","open":1.22,"high":1.22,"low":1.08,"amount":998930.0553925,"amplitude":0.111111,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-12.856861,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1760342400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":1.26,"preHourTrading":{"tag":"盘前","latestPrice":1.21,"preClose":1.26,"latestTime":"09:29 EDT","volume":24250,"amount":29426.523825,"timestamp":1760102999084},"postHourTrading":{"tag":"盘后","latestPrice":1.05,"preClose":1.11,"latestTime":"19:48 EDT","volume":32335,"amount":35213.2275,"timestamp":1760140089860},"volumeRatio":0.8184359630659397},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AMIX\",,,,,undefined,":{"symbol":"AMIX","floatShares":5565185,"roa":"-95.20%","roe":"-195.57%","lyrEps":-21.093538,"volumeRatio":0.8184359630659397,"shares":5941992,"dividePrice":0,"high":1.22,"amplitude":0.111111,"preClose":1.26,"low":1.08,"week52Low":0.9612,"pbRate":"0.94","week52High":21.49,"institutionHeld":0,"latestPrice":1.11,"eps":-12.856861,"divideRate":0,"volume":868175,"delay":0,"ttmEps":-12.856861,"open":1.22,"prevYearClose":3.76,"prevWeekClose":1.14,"prevMonthClose":1.08,"prevQuarterClose":1.08,"fiveDayClose":1.14,"twentyDayClose":1.11,"sixtyDayClose":1.65},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AMIX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-10-25","symbol":"AMIX","defaultRemindTime":1729863000000,"type":"split","dateTimestamp":1729828800000,"forFactor":20,"toFactor":1,"ratio":20}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AMIX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AMIX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":2,"updateTime":1745985600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AMIX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AMIX","date":"2025-10-10","current":-0.086335,"percent":0.464548,"low":-13.446357,"twenty":-4.079226,"median":-0.547745,"eighty":-0.319006,"high":-0.216844,"avg":-1.79839,"sd":2.638103,"marketCap":7486909},"quantilePoints":[{"date":"2024-02-02","current":-13.016254,"twenty":-12.020228,"median":-11.748584,"eighty":-11.445249,"marketCap":105524350},{"date":"2024-02-09","current":-11.884406,"twenty":-12.744611,"median":-12.008909,"eighty":-11.694255,"marketCap":96348320},{"date":"2024-02-16","current":-6.689828,"twenty":-12.495604,"median":-11.748584,"eighty":-9.339123,"marketCap":71417101},{"date":"2024-02-23","current":-7.08358,"twenty":-12.26018,"median":-11.476941,"eighty":-6.778064,"marketCap":75620597},{"date":"2024-03-01","current":-7.048515,"twenty":-11.984009,"median":-8.871831,"eighty":-6.901819,"marketCap":75246257},{"date":"2024-03-08","current":-5.374358,"twenty":-11.816495,"median":-7.647447,"eighty":-6.67112,"marketCap":57373836},{"date":"2024-03-15","current":-6.149675,"twenty":-11.757639,"median":-7.066047,"eighty":-6.204039,"marketCap":65650718},{"date":"2024-03-22","current":-5.709154,"twenty":-11.585598,"median":-6.945107,"eighty":-5.652767,"marketCap":60947944},{"date":"2024-03-28","current":-4.880974,"twenty":-11.476941,"median":-6.748784,"eighty":-5.465987,"marketCap":52106730},{"date":"2024-04-05","current":-4.889785,"twenty":-11.413557,"median":-6.607817,"eighty":-5.286254,"marketCap":52200785},{"date":"2024-04-12","current":-4.880974,"twenty":-10.76614,"median":-6.240281,"eighty":-5.025465,"marketCap":52106730},{"date":"2024-04-19","current":-5.021941,"twenty":-9.08499,"median":-5.876552,"eighty":-4.990224,"marketCap":53611617},{"date":"2024-04-26","current":-5.867918,"twenty":-7.772626,"median":-5.709154,"eighty":-5.022575,"marketCap":62642824},{"date":"2024-05-03","current":-5.744396,"twenty":-7.692486,"median":-5.744396,"eighty":-5.029941,"marketCap":61324166},{"date":"2024-05-10","current":-5.356737,"twenty":-7.527625,"median":-5.691533,"eighty":-5.029941,"marketCap":57185725},{"date":"2024-05-17","current":-4.440453,"twenty":-7.242168,"median":-5.559377,"eighty":-4.958506,"marketCap":47403956},{"date":"2024-05-24","current":-4.211382,"twenty":-7.069554,"median":-5.492065,"eighty":-4.893239,"marketCap":44958514},{"date":"2024-05-31","current":-3.735619,"twenty":-7.037907,"median":-5.4096,"eighty":-4.852781,"marketCap":39879519},{"date":"2024-06-07","current":-2.194993,"twenty":-6.985402,"median":-5.365547,"eighty":-4.757628,"marketCap":33859969},{"date":"2024-06-14","current":-1.881328,"twenty":-6.945107,"median":-5.322641,"eighty":-4.687145,"marketCap":29021367},{"date":"2024-06-21","current":-1.404888,"twenty":-6.858532,"median":-5.286254,"eighty":-4.366446,"marketCap":21671800},{"date":"2024-06-28","current":-1.233858,"twenty":-6.819267,"median":-5.285373,"eighty":-4.133851,"marketCap":19033494},{"date":"2024-07-05","current":-0.783683,"twenty":-6.748784,"median":-5.275417,"eighty":-3.96469,"marketCap":12089095},{"date":"2024-07-12","current":-0.708552,"twenty":-6.689828,"median":-5.178943,"eighty":-2.487659,"marketCap":10930125},{"date":"2024-07-15","current":-0.754975,"twenty":-6.680474,"median":-5.144494,"eighty":-2.429126,"marketCap":11646237},{"date":"2024-08-02","current":-1.258291,"twenty":-6.67112,"median":-5.110045,"eighty":-2.392543,"marketCap":19410395},{"date":"2024-08-09","current":-0.8185,"twenty":-6.614866,"median":-5.031544,"eighty":-1.746948,"marketCap":12626179},{"date":"2024-08-16","current":-0.678902,"twenty":-6.530286,"median":-4.969079,"eighty":-1.566951,"marketCap":11717848},{"date":"2024-08-23","current":-0.808829,"twenty":-6.376223,"median":-4.933837,"eighty":-1.243631,"marketCap":13960381},{"date":"2024-08-30","current":-0.766385,"twenty":-6.204039,"median":-4.889785,"eighty":-0.908657,"marketCap":13227806},{"date":"2024-09-06","current":-1.163592,"twenty":-6.121482,"median":-4.880974,"eighty":-0.908419,"marketCap":20083598},{"date":"2024-09-13","current":-1.145173,"twenty":-5.991088,"median":-4.786791,"eighty":-0.966143,"marketCap":19765688},{"date":"2024-09-20","current":-0.869424,"twenty":-5.91708,"median":-4.757628,"eighty":-0.931248,"marketCap":15006258},{"date":"2024-09-27","current":-0.782135,"twenty":-5.89597,"median":-4.695956,"eighty":-0.867778,"marketCap":13499642},{"date":"2024-10-04","current":-0.775461,"twenty":-5.864359,"median":-4.440453,"eighty":-0.840755,"marketCap":13384458},{"date":"2024-10-11","current":-0.783603,"twenty":-5.828976,"median":-4.162925,"eighty":-0.815034,"marketCap":13524983},{"date":"2024-10-18","current":-0.767453,"twenty":-5.744396,"median":-4.017553,"eighty":-0.801154,"marketCap":13246236},{"date":"2024-10-25","current":-0.660676,"twenty":-5.737348,"median":-3.682756,"eighty":-0.798098,"marketCap":11403275},{"date":"2024-10-31","current":-0.683366,"twenty":-5.709154,"median":-2.900189,"eighty":-0.790143,"marketCap":11794903},{"date":"2024-11-08","current":-0.788474,"twenty":-5.691533,"median":-2.37791,"eighty":-0.788808,"marketCap":13609060},{"date":"2024-11-15","current":-0.785853,"twenty":-5.608715,"median":-1.832463,"eighty":-0.788808,"marketCap":11023166},{"date":"2024-11-22","current":-1.110505,"twenty":-5.568187,"median":-1.722515,"eighty":-0.788808,"marketCap":15577054},{"date":"2024-11-29","current":-0.404119,"twenty":-5.554091,"median":-1.649216,"eighty":-0.787206,"marketCap":5668573},{"date":"2024-12-06","current":-0.296518,"twenty":-5.550567,"median":-1.386563,"eighty":-0.783683,"marketCap":4159257},{"date":"2024-12-13","current":-0.258735,"twenty":-5.503765,"median":-1.233858,"eighty":-0.781801,"marketCap":3629269},{"date":"2024-12-20","current":-0.246414,"twenty":-5.426093,"median":-1.173656,"eighty":-0.779652,"marketCap":3456447},{"date":"2024-12-27","current":-0.286661,"twenty":-5.4096,"median":-1.162724,"eighty":-0.772476,"marketCap":4021000},{"date":"2025-01-03","current":-0.276805,"twenty":-5.402552,"median":-1.152867,"eighty":-0.766812,"marketCap":3882742},{"date":"2025-01-10","current":-0.234915,"twenty":-5.388455,"median":-1.126704,"eighty":-0.721272,"marketCap":3295146},{"date":"2025-01-17","current":-0.234915,"twenty":-5.370834,"median":-1.094455,"eighty":-0.690174,"marketCap":3295146},{"date":"2025-01-24","current":-0.245592,"twenty":-5.356737,"median":-1.065091,"eighty":-0.664926,"marketCap":3444925},{"date":"2025-01-31","current":-0.250521,"twenty":-5.323786,"median":-0.993874,"eighty":-0.650158,"marketCap":3514054},{"date":"2025-02-07","current":-0.223415,"twenty":-5.321496,"median":-0.95965,"eighty":-0.514527,"marketCap":3133845},{"date":"2025-02-14","current":-0.234093,"twenty":-5.286254,"median":-0.921104,"eighty":-0.367978,"marketCap":3283624},{"date":"2025-02-21","current":-0.529577,"twenty":-5.286254,"median":-0.884394,"eighty":-0.396891,"marketCap":7216540},{"date":"2025-02-28","current":-0.51331,"twenty":-5.284844,"median":-0.870433,"eighty":-0.404119,"marketCap":6994871},{"date":"2025-03-07","current":-0.451857,"twenty":-5.282659,"median":-0.864124,"eighty":-0.424958,"marketCap":6157457},{"date":"2025-03-14","current":-0.370523,"twenty":-5.271347,"median":-0.855149,"eighty":-0.404119,"marketCap":5049115},{"date":"2025-03-21","current":-0.395827,"twenty":-5.261585,"median":-0.840795,"eighty":-0.370014,"marketCap":5393932},{"date":"2025-03-28","current":-0.345219,"twenty":-5.195119,"median":-0.827514,"eighty":-0.359722,"marketCap":4704297},{"date":"2025-04-04","current":-0.301841,"twenty":-5.123825,"median":-0.816667,"eighty":-0.342327,"marketCap":4113181},{"date":"2025-04-11","current":-0.296418,"twenty":-5.095949,"median":-0.808829,"eighty":-0.326745,"marketCap":4039292},{"date":"2025-04-17","current":-0.319915,"twenty":-5.060707,"median":-0.801955,"eighty":-0.319099,"marketCap":4359479},{"date":"2025-04-25","current":-0.35534,"twenty":-5.029941,"median":-0.800887,"eighty":-0.320999,"marketCap":4842224},{"date":"2025-05-02","current":-0.413901,"twenty":-5.022575,"median":-0.797617,"eighty":-0.323356,"marketCap":5640231},{"date":"2025-05-09","current":-0.307263,"twenty":-4.990224,"median":-0.789475,"eighty":-0.323356,"marketCap":4187071},{"date":"2025-05-16","current":-0.343411,"twenty":-4.958506,"median":-0.788474,"eighty":-0.320999,"marketCap":4679667},{"date":"2025-05-23","current":-0.332567,"twenty":-4.951458,"median":-0.785996,"eighty":-0.321722,"marketCap":4531888},{"date":"2025-05-30","current":-0.301841,"twenty":-4.937361,"median":-0.783988,"eighty":-0.317967,"marketCap":4113181},{"date":"2025-06-06","current":-0.336289,"twenty":-4.909097,"median":-0.783603,"eighty":-0.31883,"marketCap":3837062},{"date":"2025-06-13","current":-0.333852,"twenty":-4.894965,"median":-0.781726,"eighty":-0.320638,"marketCap":3809257},{"date":"2025-06-20","current":-0.292426,"twenty":-4.888023,"median":-0.781,"eighty":-0.31701,"marketCap":3336576},{"date":"2025-06-27","current":-0.30461,"twenty":-4.880974,"median":-0.775594,"eighty":-0.314854,"marketCap":3475600},{"date":"2025-07-03","current":-0.346037,"twenty":-4.880974,"median":-0.774126,"eighty":-0.3163,"marketCap":3948281},{"date":"2025-07-11","current":-0.367969,"twenty":-4.845733,"median":-0.767586,"eighty":-0.3163,"marketCap":4198524},{"date":"2025-07-18","current":-0.402085,"twenty":-4.801681,"median":-0.754975,"eighty":-0.316794,"marketCap":4587792},{"date":"2025-07-25","current":-0.350911,"twenty":-4.771901,"median":-0.713978,"eighty":-0.317874,"marketCap":4003891},{"date":"2025-08-01","current":-0.350911,"twenty":-4.757628,"median":-0.696046,"eighty":-0.317874,"marketCap":4003891},{"date":"2025-08-08","current":-0.302173,"twenty":-4.757628,"median":-0.681134,"eighty":-0.316794,"marketCap":3447795},{"date":"2025-08-15","current":-0.260785,"twenty":-4.740008,"median":-0.660908,"eighty":-0.314493,"marketCap":3141942},{"date":"2025-08-22","current":-0.337222,"twenty":-4.704766,"median":-0.65435,"eighty":-0.314493,"marketCap":4062851},{"date":"2025-08-29","current":-0.515256,"twenty":-4.687145,"median":-0.552729,"eighty":-0.314493,"marketCap":6207806},{"date":"2025-09-05","current":-0.503546,"twenty":-4.517985,"median":-0.552729,"eighty":-0.315939,"marketCap":6066719},{"date":"2025-09-12","current":-0.543361,"twenty":-4.447501,"median":-0.545703,"eighty":-0.3163,"marketCap":6546413},{"date":"2025-09-19","current":-0.517853,"twenty":-4.41226,"median":-0.548045,"eighty":-0.316695,"marketCap":6239091},{"date":"2025-09-26","current":-0.507989,"twenty":-4.250148,"median":-0.545403,"eighty":-0.317658,"marketCap":6120251},{"date":"2025-10-03","current":-0.577036,"twenty":-4.133851,"median":-0.543361,"eighty":-0.31806,"marketCap":6952130},{"date":"2025-10-10","current":-0.621423,"twenty":-4.079226,"median":-0.547745,"eighty":-0.319006,"marketCap":7486909}],"updateTime":1760215240061},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AMIX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2553552292","title":"Autonomix Medical, Inc. Exercise of Warrants for $2.5 Million Gross Proceeds","url":"https://stock-news.laohu8.com/highlight/detail?id=2553552292","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553552292?lang=en_us&edition=fundamental","pubTime":"2025-07-22 20:30","pubTimestamp":1753187400,"startTime":"0","endTime":"0","summary":"THE WOODLANDS, TX, July  22, 2025  (GLOBE NEWSWIRE) -- Autonomix Medical, Inc.(NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted tr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/22/3119417/0/en/Autonomix-Medical-Inc-Exercise-of-Warrants-for-2-5-Million-Gross-Proceeds.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMIX","BK4082"],"gpt_icon":0},{"id":"2553472751","title":"Autonomix Medical, Inc. Granted New U.S. Patent to Advance Minimally Invasive, Nerve-Focused Treatments Across High-Need Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2553472751","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553472751?lang=en_us&edition=fundamental","pubTime":"2025-07-21 20:45","pubTimestamp":1753101900,"startTime":"0","endTime":"0","summary":"With over 80 issued patents and 40 pending patent applications, Autonomix is building a comprehensive IP portfolio in nerve-sensing and modulation, strengthening its strategic position in a multi-bill","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/21/3118741/0/en/Autonomix-Medical-Inc-Granted-New-U-S-Patent-to-Advance-Minimally-Invasive-Nerve-Focused-Treatments-Across-High-Need-Indications.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AMIX"],"gpt_icon":0},{"id":"2549532127","title":"Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment","url":"https://stock-news.laohu8.com/highlight/detail?id=2549532127","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549532127?lang=en_us&edition=fundamental","pubTime":"2025-07-07 20:30","pubTimestamp":1751891400,"startTime":"0","endTime":"0","summary":"THE WOODLANDS, TX, July  07, 2025  (GLOBE NEWSWIRE) -- Autonomix Medical, Inc.(NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted tr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/07/3111015/0/en/Autonomix-Medical-Inc-Announces-Release-of-the-Next-CEO-Corner-Segment.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AMIX"],"gpt_icon":0},{"id":"2547091945","title":"BRIEF-Autonomix Medical Inc - Enrolls First Patient In Poc 2 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2547091945","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547091945?lang=en_us&edition=fundamental","pubTime":"2025-06-30 20:34","pubTimestamp":1751286883,"startTime":"0","endTime":"0","summary":"BRIEF-Autonomix Medical Inc - Enrolls First Patient In Poc 2 Clinical TrialAutonomix Medical Inc AMIX.O:AUTONOMIX MEDICAL INC - ENROLLS FIRST PATIENT IN POC 2 CLINICAL TRIALSource text: ID:nGNX2yDVxFFurther company coverage: AMIX.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nFWN3SX0I3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AMIX"],"gpt_icon":0},{"id":"2546743483","title":"BRIEF-Autonomix Medical Granted US Patent for Innovative Catheter-Based Platform Technology for Nerve Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2546743483","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546743483?lang=en_us&edition=fundamental","pubTime":"2025-06-27 20:04","pubTimestamp":1751025892,"startTime":"0","endTime":"0","summary":"BRIEF-Autonomix Medical Granted US Patent for Innovative Catheter-Based Platform Technology for Nerve TherapyJune 27 (Reuters) - Autonomix Medical Inc AMIX.O:AUTONOMIX MEDICAL, INC. GRANTED NEW U.S. P","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250627:nFWN3ST184:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AMIX"],"gpt_icon":0},{"id":"2541193079","title":"Autonomix Medical Approved to Begin Testing Treatment for Cancer-Related Pain in Uzbekistan","url":"https://stock-news.laohu8.com/highlight/detail?id=2541193079","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541193079?lang=en_us&edition=fundamental","pubTime":"2025-06-05 22:36","pubTimestamp":1749134188,"startTime":"0","endTime":"0","summary":"Autonomix Medical  said Thursday that regulators in Uzbekistan have approved the start of a clinical trial evaluating the safety and efficacy of using transvascular energy to ablate problematic nerves to mitigate pain in patients with various types of cancer.Autonomix said it is on track to commence enrollment this month.The company previously led proof-of-concept testing of its pain therapy in patients with pancreatic cancer but said it believes its process could eventually be used to treat other conditions, with potential applications for cardiology, gastroenterology and hypertension, as well as treating chronic pain.Autonomix Medical shares were 14% lower in recent trading.Price: 1.38, Change: -0.24, Percent Change: -14.81","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","AMIX"],"gpt_icon":1},{"id":"2539296410","title":"Autonomix Medical Inc. Reports Uncertain Revenue Outlook Amid Ongoing R&D Expenses; Net Loss Widens as EPS Declines","url":"https://stock-news.laohu8.com/highlight/detail?id=2539296410","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539296410?lang=en_us&edition=fundamental","pubTime":"2025-05-30 05:01","pubTimestamp":1748552507,"startTime":"0","endTime":"0","summary":"Autonomix Medical Inc., a development stage medical device company, has released its annual report for the fiscal year ending March 31, 2025. The company is focused on advancing technologies for sensing and treating nervous system disorders, with an initial focus on patients with pancreatic cancer. The report indicates that Autonomix Medical is in the research and development phase and has not yet achieved regulatory approval or commercialization of its device, which means it has not generated revenue from sales. The company's operating expenses are classified into three categories: research and development, general and administrative, and warrant expense - termination agreement. Research and development expenses are primarily driven by costs associated with animal research, design and development of technology, and salaries for employees engaged in these activities. Autonomix Medical highlights the uncertainties involved in obtaining necessary regulatory approvals and the commercializ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250529:nNDLbdRgXL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Autonomix Medical Inc. Reports Uncertain Revenue Outlook Amid Ongoing R&D Expenses; Net Loss Widens as EPS Declines","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMIX"],"gpt_icon":0},{"id":"2531319260","title":"BRIEF-Autonomix Medical Reports Positive Outcomes In Initial Phase Of First-In-Human Proof-Of-Concept Trial In Pancreatic Cancer Pain And Initiates Market Expansion Study For Visceral Cancer Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2531319260","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531319260?lang=en_us&edition=fundamental","pubTime":"2025-04-30 20:17","pubTimestamp":1746015475,"startTime":"0","endTime":"0","summary":"BRIEF-Autonomix Medical Reports Positive Outcomes In Initial Phase Of First-In-Human Proof-Of-Concept Trial In Pancreatic Cancer Pain And Initiates Market Expansion Study For Visceral Cancer PainApril","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nTUABQTWRL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AMIX"],"gpt_icon":0},{"id":"2531515758","title":"Autonomix Medical Initiated at Buy by Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2531515758","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531515758?lang=en_us&edition=fundamental","pubTime":"2025-04-29 21:48","pubTimestamp":1745934480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AMIX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 29, 2025 09:48 ET (13:48 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AMIX"],"gpt_icon":0},{"id":"2531979738","title":"Maxim Group Initiates Coverage on Autonomix Medical With Buy Rating, $5 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2531979738","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531979738?lang=en_us&edition=fundamental","pubTime":"2025-04-29 20:12","pubTimestamp":1745928723,"startTime":"0","endTime":"0","summary":"Autonomix Medical (AMIX) has an average rating of Buy and mean price target of $11.50, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major b","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AMIX"],"gpt_icon":0},{"id":"2527221145","title":"BRIEF-Autonomix Medical Granted New European Patent For Proprietary Catheter-Based Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2527221145","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527221145?lang=en_us&edition=fundamental","pubTime":"2025-04-16 20:40","pubTimestamp":1744807243,"startTime":"0","endTime":"0","summary":"BRIEF-Autonomix Medical Granted New European Patent For Proprietary Catheter-Based TechnologyApril 16 (Reuters) - Autonomix Medical Inc AMIX.O:AUTONOMIX MEDICAL, INC. GRANTED NEW EUROPEAN PATENT FOR P","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nFWN3QU1SC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AMIX"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":31,"code":"91000000","status":"200"}]}}